Lv1
86 积分 2024-10-25 加入
First-in-human in vivo CAR T-cell generation using a CD8-targeted lipid nanoparticle platform in relapsed/refractory B-cell lymphoma
4天前
求助中
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
5天前
已完结
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
5天前
已完结
Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
5天前
已关闭
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
7天前
已完结
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
8天前
已完结
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
9天前
已完结
Therapy with oncolytic viruses: progress and challenges
9天前
已完结
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
9天前
已完结
Phase 1 study of B440, an oral Bifidobacterium -engineered WT1 cancer vaccine, in patients with metastatic urothelial cancer
9天前
已关闭
皖公网安备34019202002308
